SlideShare uma empresa Scribd logo
1 de 45
بسم الله الرحمن الرحيم
ACKNOWLEDGMENT Prof. Dr. Mohamed Khairy Makled Professor of Parasitology Faculty of Medicine, Ain Shams University Prof. Dr. Mohamed Al-Hussieny Fayad Professor of Parasitology Faculty of Medicine, Ain Shams University Prof. Dr.  Abd-Al Magid Mohamed Kamal Professor of Parasitology Faculty of Medicine, Ain Shams University Dr. Magid Mustafa Al-Sherbiny Assistant Professor of Zoology Faculty of Science, Cairo University   Dr. Gihan Mustafa Tawfeek Assistant Professor of Parasitology Faculty of Medicine, Ain Shams University
APPLICATION & ASSESSMENT OF IMMUNOCHROMATOGRAPHIC  STRIPS & DIPSTICKS IN DIAGNOSIS OF SOME PARASITIC DISEASES
INTRODUCTION   ,[object Object],[object Object]
[object Object],DIPSTICKS ,[object Object]
APPLICATIONS OF DIPSTICKS IN PARASITOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object]
ICS ,[object Object],[object Object],[object Object]
APPLICATIONS OF ICS IN PARASITOLOGY ,[object Object],1.  ANTIGEN  DETECTION  ICS ,[object Object],[object Object]
[object Object],[object Object],[object Object]
AIM OF THE WORK ,[object Object],[object Object],[object Object]
MATERIALS & METHODS ,[object Object],[object Object],[object Object],[object Object],[object Object]
4c 4b + Patients with  1. Ascarisis 2. Cysticercosi 3.  Alveolar Echin.  4. Onchocerciasis  5. Filariasis (For dipsticks& ICS)   3c   3b + Patients with  1. Ascarisis 2. Cysticercosis 3. Alveolar Ech. 4. Onchocerciasis  5. Filariasis (For dipsticks &ICS)   1c   1b + Patients with  1. Ascarisis 2. Cysticercosis 3. Alveolar Ech. 4. Onchocerciasis 5. Filariasis (For dipsticks & ICS) Control Sera 4b Patients with  1.Hydatidodid 2. Toxoplasmosis  3. Schistosomiasis 4. Amoebiasis  5. Fascioliasis. (For EITB and FAST-ELISA) 3b Patients with  1.Hydatidosis 2. Trichinosis  3.Schistosomiasis  4. Amoebiasis  5. Fascioliasis. (For EITB and FAST-ELISA) Schistosomiasis Patients 1b   Patients with 1.Toxoplasmosis 2. Trichinosis  3.Schistosomiasis 4. Amoebiasis  5. Fascioliasis. (For EITB and FAST-ELISA)   4a Trichinosis patients 3a  Toxoplasmosis Patients 1a Hydatidosis  patients  Group 5 Group 4 Group 3    Group 2    Group 1
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Experimental Study Clinical Study Evaluation of reactivity of these antigens to the collected Sera EITB  FAST-ELISA EITB  ELISA Dipsticks 1. Preparation 2.  Assay ICS 1. Preparation 2. Assay
RESULTS
Reaction of Hydatidosis Patients, Normal Controls & Sera of other parasitic Diseases in EITB HYDATIDOSIS EITB
%positive reactions of sera of  hydatidosis patients, patients with other parasitic infections and normal controls with different bands of crude HCF antigen bands in EITB  HYDATIDOSIS EITB
Reaction of sera of hydatidosis patients, patients with other  parasitic diseases and normal controls to crude HCF antigen by FAST-ELISA HYDATIDOSIS FAST-ELISA
Reactions of hydatidosis patients, normal controls and heterologous sera to crude HCF antigen in dipstick  assay HYDATIDOSIS DIPSTICKS
[object Object],HYDATIDOSIS DIPSTICKS
ICS using crude HCF antigen tested in hydatidosis patients, normal control sera, PBS and D.water  HYDATIDOSIS ICS
HYDATIDOSIS   Tests   Sensitivity   Specificity   Efficiency Predictive value +ve PV -ve PV EITB     100%   91.4%   95.1%   89.7%   100%   FAST ELISA     96.2%   100%   98.4%   100%   97.2%   Dipsticks     100%   91.4%   95.1%   89.7%   100%
Reactions of Schistosomiasis patient and normal control sera with  S.mansoni  specific fraction in EITB Reactions of Schistosomiasis patient and normal control sera with  S.haematobium  specific fraction in EITB SCHISTOSOMIASIS EITB
% positive reactions of sera of schistosomiasis patients and normal controls with different bands of MAMA and HAMA in EITB SCHISTOSOMIASIS EITB
SCHISTOSOMIASIS Number and percentage of positive reactions by FAST ELISA using MAMA  FAST-ELISA   Groups   Total number of tested sera No. (%)  Positive MAMA-FASTELISA   Schistosomiasis patients       30     29 (96.7)   Normal control     10   0 (0)
Reactions of Schistosomiasis patients and normal controls sera to  S.mansoni  Gp30 and  S.haematobium  Gp23 in dipsticks assay SCHISTOSOMIASIS DIPSTICKS
ICS using GP30 of  S.mansoni   SCHISTOSOMIASIS ICS using GP23 specific for  S.haematobium ICS
SCHISTOSOMIASIS   Tests   Sensitivity   Specificity   Efficiency Predictive value (PV) +ve PV -ve PV   EITB     96.7%   100%   97.5 %   100 %   90.9%   FAST ELISA     96.7%   100 %   97 .5 %   100%   90.9%   Dipsticks   96.7%   100 %   97.5 %     100%   90.9%  
TOXOPLASMOSIS EITB analysis of antibody responses to crude tachyzoite antigen for sera from toxoplasmosis patient, controls, and sera of  patients with other parasitic diseases   EITB
% positive reactions of sera of toxoplasmosis patients, patients with other parasitic infections and normal controls with different bands of crude tachyzoite antigen  TOXOPLASMOSIS EITB
Reaction of sera of toxoplasmosis patients, patients of other parasitic diseases and normal controls to crude tachyzoite antigen by FAST-ELISA TOXOPLASMOSIS FAST-ELISA
Reactions of toxoplasmosis patients’ sera, normal control and heterologous sera in dipstick assay TOXOPLASMOSIS DIPSTICKS
ICS using crude tachyzoites antigen of  T.gondii  TOXOPLASMOSIS ICS
TOXOPLASMOSIS Comparison between results of EITB, and FAST-ELISA in toxoplasmosis patients and controls   Tests   Sensitivity   Specificity   Efficiency Predictive value   +ve PV -ve PV   EITB   100%   100%   100%   100 %   100%   FAST ELISA   95.5%   94.3%   94.7%   91.3%   97.1%
Reaction of trichinosis patients, normal controls, and sera of different parasitic diseases in EITB TRICHINOSIS EITB
%positive reactions of sera of trichinosis patients and normal controls with different bands of  Trichinella  antigen   TRICHINOSIS EITB
Reaction of sera of trichinosis patients, patients of other parasitic diseases and normal controls to crude larval antigen of  T.spiralis  by FAST-ELISA   TRICHINOSIS FAST-ELISA
TRICHINOSIS Reactions of sera of trichinosis patients,  normal controls, and heterologous sera to  T.spiralis  antigen in Dipstick DIPSTICKS
TRICHINOSIS % positive reactions of trichinosis patients’ sera, sera of patients with different parasitic diseases & normal control in dipstick assay.   DIPSTICKS
TRICHINOSIS ICS using the crude  T.spiralis  larval antigen   ICS
TRICHINOSIS   Tests   Sensitivity   Specificity   Efficiency Predictive value   +ve PV -ve PV   EITB   100%   100%   100%   100%   100%   FAST ELISA   85.7%   85.7%   85.7%   54.5%   96.8%   Dipsticks   100%   100%   100%   100%   100%
TRICHINOSIS Reactions of experimentally infected mice sera at different time interval post infection to  Trichinella  antigen by EITB and dipsticks EXP. STUDY EITB DIPSTICKS
[object Object],[object Object],[object Object],CONCLUSION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],RECOMMENDATION
THANKS

Mais conteúdo relacionado

Mais procurados

Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...
Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...
Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...spa718
 
The role of tumor necrosis factor final.for puplication
The role of tumor necrosis factor final.for puplicationThe role of tumor necrosis factor final.for puplication
The role of tumor necrosis factor final.for puplicationShendy Sherif
 
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...AdeyemiKayode2
 
PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"StopTb Italia
 
Can Meropenem Heteroresistance in OXA-48-Producing K. pneumoniae be Inferred...
Can Meropenem Heteroresistance in OXA-48-Producing  K. pneumoniae be Inferred...Can Meropenem Heteroresistance in OXA-48-Producing  K. pneumoniae be Inferred...
Can Meropenem Heteroresistance in OXA-48-Producing K. pneumoniae be Inferred...PROANTIBIOTICOS
 
Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...
Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...
Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...Apollo Hospitals
 
Treatment of Legionnaires’ Disease
Treatment of Legionnaires’ DiseaseTreatment of Legionnaires’ Disease
Treatment of Legionnaires’ DiseaseJordi Roig
 
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...WAidid
 
PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"StopTb Italia
 
Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...
Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...
Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...Dr Muktikesh Dash, MD, PGDFM
 
SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?
SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?
SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?Nuhu Tanko
 
ICAAC2008-nz2114 timekill F1-3963 v4.PPT
ICAAC2008-nz2114 timekill F1-3963 v4.PPTICAAC2008-nz2114 timekill F1-3963 v4.PPT
ICAAC2008-nz2114 timekill F1-3963 v4.PPTVenkat Alluru
 
In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...
In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...
In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...EuFMD
 
Nigeria epidemiology and challenges ifi
Nigeria epidemiology and challenges ifiNigeria epidemiology and challenges ifi
Nigeria epidemiology and challenges ififungalinfection
 
重症病患抗生素使用961113
重症病患抗生素使用961113重症病患抗生素使用961113
重症病患抗生素使用961113calaf0618
 
Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...
Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...
Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...Premier Publishers
 

Mais procurados (20)

Antibiogram
AntibiogramAntibiogram
Antibiogram
 
Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...
Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...
Breakthroughs in the treatment of acute promyelocytic leukemia: curable disea...
 
PAPER1
PAPER1PAPER1
PAPER1
 
The role of tumor necrosis factor final.for puplication
The role of tumor necrosis factor final.for puplicationThe role of tumor necrosis factor final.for puplication
The role of tumor necrosis factor final.for puplication
 
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
 
PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"
 
Can Meropenem Heteroresistance in OXA-48-Producing K. pneumoniae be Inferred...
Can Meropenem Heteroresistance in OXA-48-Producing  K. pneumoniae be Inferred...Can Meropenem Heteroresistance in OXA-48-Producing  K. pneumoniae be Inferred...
Can Meropenem Heteroresistance in OXA-48-Producing K. pneumoniae be Inferred...
 
Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...
Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...
Incidence rate of multidrug-resistant organisms in a tertiary care hospital, ...
 
Treatment of Legionnaires’ Disease
Treatment of Legionnaires’ DiseaseTreatment of Legionnaires’ Disease
Treatment of Legionnaires’ Disease
 
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...
 
Changes in CLSI 2017
Changes in CLSI 2017Changes in CLSI 2017
Changes in CLSI 2017
 
PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"
 
Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...
Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...
Enterococcal infectionsresistance and antimicrobial in a tertiary care hospit...
 
SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?
SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?
SALMONELLA ARIZOANE: AN UNCOMMON UROPATHOGEN?
 
ICAAC2008-nz2114 timekill F1-3963 v4.PPT
ICAAC2008-nz2114 timekill F1-3963 v4.PPTICAAC2008-nz2114 timekill F1-3963 v4.PPT
ICAAC2008-nz2114 timekill F1-3963 v4.PPT
 
In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...
In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...
In-vitro Correlates of Heterologous Protection using Avidity and IgG-Subtypin...
 
Nigeria epidemiology and challenges ifi
Nigeria epidemiology and challenges ifiNigeria epidemiology and challenges ifi
Nigeria epidemiology and challenges ifi
 
重症病患抗生素使用961113
重症病患抗生素使用961113重症病患抗生素使用961113
重症病患抗生素使用961113
 
Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...
Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...
Antibiogram of Bacteria Isolated from Wounds of Diabetic Patients on Admissio...
 
Comparative Evaluation of ENTEROSCREEN-WBTM and Widal test in Suspected Cases...
Comparative Evaluation of ENTEROSCREEN-WBTM and Widal test in Suspected Cases...Comparative Evaluation of ENTEROSCREEN-WBTM and Widal test in Suspected Cases...
Comparative Evaluation of ENTEROSCREEN-WBTM and Widal test in Suspected Cases...
 

Destaque

Factm malaria 2
Factm malaria 2Factm malaria 2
Factm malaria 2Tim Inglis
 
Parasitology revision 2016 mod ug
Parasitology revision 2016 mod ugParasitology revision 2016 mod ug
Parasitology revision 2016 mod ugMohammed Sarhan
 
Chapt12 Holes Lecture Animation[1]
Chapt12 Holes Lecture Animation[1]Chapt12 Holes Lecture Animation[1]
Chapt12 Holes Lecture Animation[1]bholmes
 
1.general introduction to medical parasitology
1.general introduction to medical parasitology1.general introduction to medical parasitology
1.general introduction to medical parasitologyHelder Jorge Semedo Pires
 
MCQs Techniques
MCQs TechniquesMCQs Techniques
MCQs TechniquesFayzaRayes
 
Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)Suraj Chhetri
 

Destaque (8)

Factm malaria 2
Factm malaria 2Factm malaria 2
Factm malaria 2
 
Parasitology revision 2016 mod ug
Parasitology revision 2016 mod ugParasitology revision 2016 mod ug
Parasitology revision 2016 mod ug
 
Chapt12 Holes Lecture Animation[1]
Chapt12 Holes Lecture Animation[1]Chapt12 Holes Lecture Animation[1]
Chapt12 Holes Lecture Animation[1]
 
Anatomy of lacrimal apparatus
Anatomy of lacrimal apparatusAnatomy of lacrimal apparatus
Anatomy of lacrimal apparatus
 
1.general introduction to medical parasitology
1.general introduction to medical parasitology1.general introduction to medical parasitology
1.general introduction to medical parasitology
 
MCQs Techniques
MCQs TechniquesMCQs Techniques
MCQs Techniques
 
Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)
 
Lacrimal system
Lacrimal system Lacrimal system
Lacrimal system
 

Semelhante a Nehad m. sayed (ain shams)1

DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCKDIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCKrinkusarawade
 
The effect of chemotherapy on the serological respons of patients with schist...
The effect of chemotherapy on the serological respons of patients with schist...The effect of chemotherapy on the serological respons of patients with schist...
The effect of chemotherapy on the serological respons of patients with schist...Alim A-H Yacoub Lovers
 
identification and characterization of Staphylococuss. aureus from ready to e...
identification and characterization of Staphylococuss. aureus from ready to e...identification and characterization of Staphylococuss. aureus from ready to e...
identification and characterization of Staphylococuss. aureus from ready to e...Ruhely Nath
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisAbhijit Chaudhury
 
A comparative study of various diagnostic techniques for Cryptosporidiosis
A comparative study of various diagnostic techniques for CryptosporidiosisA comparative study of various diagnostic techniques for Cryptosporidiosis
A comparative study of various diagnostic techniques for CryptosporidiosisIOSR Journals
 
Advances in diagnosis of salmonellosis and characterization of salmonella
Advances in diagnosis of salmonellosis and characterization of salmonellaAdvances in diagnosis of salmonellosis and characterization of salmonella
Advances in diagnosis of salmonellosis and characterization of salmonellaBhoj Raj Singh
 
DIAGNOSIS OF PARASITIC ZOONOSES
DIAGNOSIS OF PARASITIC ZOONOSESDIAGNOSIS OF PARASITIC ZOONOSES
DIAGNOSIS OF PARASITIC ZOONOSESAnusha Anu
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Scientific Review
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...Scientific Review SR
 
Diagnosis of Tuberculosis
Diagnosis of TuberculosisDiagnosis of Tuberculosis
Diagnosis of TuberculosisRohit Vikas
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...iosrphr_editor
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseasesSpringer
 
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...iosrjce
 
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...Premier Publishers
 

Semelhante a Nehad m. sayed (ain shams)1 (20)

DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCKDIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
 
pcr.pdf
pcr.pdfpcr.pdf
pcr.pdf
 
The effect of chemotherapy on the serological respons of patients with schist...
The effect of chemotherapy on the serological respons of patients with schist...The effect of chemotherapy on the serological respons of patients with schist...
The effect of chemotherapy on the serological respons of patients with schist...
 
identification and characterization of Staphylococuss. aureus from ready to e...
identification and characterization of Staphylococuss. aureus from ready to e...identification and characterization of Staphylococuss. aureus from ready to e...
identification and characterization of Staphylococuss. aureus from ready to e...
 
Eman journal
Eman  journalEman  journal
Eman journal
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosis
 
FEMS_Final.pdf
FEMS_Final.pdfFEMS_Final.pdf
FEMS_Final.pdf
 
A comparative study of various diagnostic techniques for Cryptosporidiosis
A comparative study of various diagnostic techniques for CryptosporidiosisA comparative study of various diagnostic techniques for Cryptosporidiosis
A comparative study of various diagnostic techniques for Cryptosporidiosis
 
Advances in diagnosis of salmonellosis and characterization of salmonella
Advances in diagnosis of salmonellosis and characterization of salmonellaAdvances in diagnosis of salmonellosis and characterization of salmonella
Advances in diagnosis of salmonellosis and characterization of salmonella
 
220614-FEMS-2022-TmpSmx_final.pdf
220614-FEMS-2022-TmpSmx_final.pdf220614-FEMS-2022-TmpSmx_final.pdf
220614-FEMS-2022-TmpSmx_final.pdf
 
DIAGNOSIS OF PARASITIC ZOONOSES
DIAGNOSIS OF PARASITIC ZOONOSESDIAGNOSIS OF PARASITIC ZOONOSES
DIAGNOSIS OF PARASITIC ZOONOSES
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
 
Diagnosis of Tuberculosis
Diagnosis of TuberculosisDiagnosis of Tuberculosis
Diagnosis of Tuberculosis
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 
Acae Nicu Paper Final Subm Correction
Acae Nicu Paper Final Subm CorrectionAcae Nicu Paper Final Subm Correction
Acae Nicu Paper Final Subm Correction
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
Study on Sensitivity Pattern of Micro-Organisms in Respiratory Tract Infectio...
 
ijep-03-22531-1
ijep-03-22531-1ijep-03-22531-1
ijep-03-22531-1
 
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
A study of antibiotic resistance of Extended-Spectrum Beta-Lactamases produci...
 

Último

HTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation StrategiesHTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation StrategiesBoston Institute of Analytics
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdflior mazor
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationRadu Cotescu
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024The Digital Insurer
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfhans926745
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoffsammart93
 
What Are The Drone Anti-jamming Systems Technology?
What Are The Drone Anti-jamming Systems Technology?What Are The Drone Anti-jamming Systems Technology?
What Are The Drone Anti-jamming Systems Technology?Antenna Manufacturer Coco
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Enterprise Knowledge
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsJoaquim Jorge
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024The Digital Insurer
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Scriptwesley chun
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptxHampshireHUG
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationMichael W. Hawkins
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Miguel Araújo
 
Boost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivityBoost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivityPrincipled Technologies
 

Último (20)

HTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation StrategiesHTML Injection Attacks: Impact and Mitigation Strategies
HTML Injection Attacks: Impact and Mitigation Strategies
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdf
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
What Are The Drone Anti-jamming Systems Technology?
What Are The Drone Anti-jamming Systems Technology?What Are The Drone Anti-jamming Systems Technology?
What Are The Drone Anti-jamming Systems Technology?
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
Boost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivityBoost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivity
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 

Nehad m. sayed (ain shams)1

  • 2. ACKNOWLEDGMENT Prof. Dr. Mohamed Khairy Makled Professor of Parasitology Faculty of Medicine, Ain Shams University Prof. Dr. Mohamed Al-Hussieny Fayad Professor of Parasitology Faculty of Medicine, Ain Shams University Prof. Dr. Abd-Al Magid Mohamed Kamal Professor of Parasitology Faculty of Medicine, Ain Shams University Dr. Magid Mustafa Al-Sherbiny Assistant Professor of Zoology Faculty of Science, Cairo University   Dr. Gihan Mustafa Tawfeek Assistant Professor of Parasitology Faculty of Medicine, Ain Shams University
  • 3. APPLICATION & ASSESSMENT OF IMMUNOCHROMATOGRAPHIC STRIPS & DIPSTICKS IN DIAGNOSIS OF SOME PARASITIC DISEASES
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. 4c 4b + Patients with 1. Ascarisis 2. Cysticercosi 3. Alveolar Echin. 4. Onchocerciasis 5. Filariasis (For dipsticks& ICS)   3c   3b + Patients with 1. Ascarisis 2. Cysticercosis 3. Alveolar Ech. 4. Onchocerciasis 5. Filariasis (For dipsticks &ICS)   1c   1b + Patients with 1. Ascarisis 2. Cysticercosis 3. Alveolar Ech. 4. Onchocerciasis 5. Filariasis (For dipsticks & ICS) Control Sera 4b Patients with 1.Hydatidodid 2. Toxoplasmosis 3. Schistosomiasis 4. Amoebiasis 5. Fascioliasis. (For EITB and FAST-ELISA) 3b Patients with 1.Hydatidosis 2. Trichinosis 3.Schistosomiasis 4. Amoebiasis 5. Fascioliasis. (For EITB and FAST-ELISA) Schistosomiasis Patients 1b   Patients with 1.Toxoplasmosis 2. Trichinosis 3.Schistosomiasis 4. Amoebiasis 5. Fascioliasis. (For EITB and FAST-ELISA) 4a Trichinosis patients 3a Toxoplasmosis Patients 1a Hydatidosis patients Group 5 Group 4 Group 3   Group 2   Group 1
  • 13.
  • 15. Reaction of Hydatidosis Patients, Normal Controls & Sera of other parasitic Diseases in EITB HYDATIDOSIS EITB
  • 16. %positive reactions of sera of hydatidosis patients, patients with other parasitic infections and normal controls with different bands of crude HCF antigen bands in EITB HYDATIDOSIS EITB
  • 17. Reaction of sera of hydatidosis patients, patients with other parasitic diseases and normal controls to crude HCF antigen by FAST-ELISA HYDATIDOSIS FAST-ELISA
  • 18. Reactions of hydatidosis patients, normal controls and heterologous sera to crude HCF antigen in dipstick assay HYDATIDOSIS DIPSTICKS
  • 19.
  • 20. ICS using crude HCF antigen tested in hydatidosis patients, normal control sera, PBS and D.water HYDATIDOSIS ICS
  • 21. HYDATIDOSIS   Tests   Sensitivity   Specificity   Efficiency Predictive value +ve PV -ve PV EITB     100%   91.4%   95.1%   89.7%   100%   FAST ELISA     96.2%   100%   98.4%   100%   97.2%   Dipsticks     100%   91.4%   95.1%   89.7%   100%
  • 22. Reactions of Schistosomiasis patient and normal control sera with S.mansoni specific fraction in EITB Reactions of Schistosomiasis patient and normal control sera with S.haematobium specific fraction in EITB SCHISTOSOMIASIS EITB
  • 23. % positive reactions of sera of schistosomiasis patients and normal controls with different bands of MAMA and HAMA in EITB SCHISTOSOMIASIS EITB
  • 24. SCHISTOSOMIASIS Number and percentage of positive reactions by FAST ELISA using MAMA FAST-ELISA   Groups   Total number of tested sera No. (%) Positive MAMA-FASTELISA   Schistosomiasis patients       30     29 (96.7)   Normal control     10   0 (0)
  • 25. Reactions of Schistosomiasis patients and normal controls sera to S.mansoni Gp30 and S.haematobium Gp23 in dipsticks assay SCHISTOSOMIASIS DIPSTICKS
  • 26. ICS using GP30 of S.mansoni SCHISTOSOMIASIS ICS using GP23 specific for S.haematobium ICS
  • 27. SCHISTOSOMIASIS   Tests   Sensitivity   Specificity   Efficiency Predictive value (PV) +ve PV -ve PV   EITB     96.7%   100%   97.5 %   100 %   90.9%   FAST ELISA     96.7%   100 %   97 .5 %   100%   90.9%   Dipsticks   96.7%   100 %   97.5 %     100%   90.9%  
  • 28. TOXOPLASMOSIS EITB analysis of antibody responses to crude tachyzoite antigen for sera from toxoplasmosis patient, controls, and sera of patients with other parasitic diseases EITB
  • 29. % positive reactions of sera of toxoplasmosis patients, patients with other parasitic infections and normal controls with different bands of crude tachyzoite antigen TOXOPLASMOSIS EITB
  • 30. Reaction of sera of toxoplasmosis patients, patients of other parasitic diseases and normal controls to crude tachyzoite antigen by FAST-ELISA TOXOPLASMOSIS FAST-ELISA
  • 31. Reactions of toxoplasmosis patients’ sera, normal control and heterologous sera in dipstick assay TOXOPLASMOSIS DIPSTICKS
  • 32. ICS using crude tachyzoites antigen of T.gondii TOXOPLASMOSIS ICS
  • 33. TOXOPLASMOSIS Comparison between results of EITB, and FAST-ELISA in toxoplasmosis patients and controls   Tests   Sensitivity   Specificity   Efficiency Predictive value +ve PV -ve PV   EITB   100%   100%   100%   100 %   100%   FAST ELISA   95.5%   94.3%   94.7%   91.3%   97.1%
  • 34. Reaction of trichinosis patients, normal controls, and sera of different parasitic diseases in EITB TRICHINOSIS EITB
  • 35. %positive reactions of sera of trichinosis patients and normal controls with different bands of Trichinella antigen TRICHINOSIS EITB
  • 36. Reaction of sera of trichinosis patients, patients of other parasitic diseases and normal controls to crude larval antigen of T.spiralis by FAST-ELISA   TRICHINOSIS FAST-ELISA
  • 37. TRICHINOSIS Reactions of sera of trichinosis patients, normal controls, and heterologous sera to T.spiralis antigen in Dipstick DIPSTICKS
  • 38. TRICHINOSIS % positive reactions of trichinosis patients’ sera, sera of patients with different parasitic diseases & normal control in dipstick assay. DIPSTICKS
  • 39. TRICHINOSIS ICS using the crude T.spiralis larval antigen ICS
  • 40. TRICHINOSIS   Tests   Sensitivity   Specificity   Efficiency Predictive value +ve PV -ve PV   EITB   100%   100%   100%   100%   100%   FAST ELISA   85.7%   85.7%   85.7%   54.5%   96.8%   Dipsticks   100%   100%   100%   100%   100%
  • 41. TRICHINOSIS Reactions of experimentally infected mice sera at different time interval post infection to Trichinella antigen by EITB and dipsticks EXP. STUDY EITB DIPSTICKS
  • 42.
  • 43.
  • 44.